Why did my focus change in perimenopause? What I tell patients.

What Do I Actually Say When a Patient Asks This?

I say: your focus didn't get worse because you got lazier, older, or less disciplined. It got worse because a hormone that was quietly propping up your dopamine system for twenty-plus years started swinging unpredictably instead of holding steady. I don't lead with the receptor biology. I lead with that reframe, because it's the part that changes how a patient feels walking out of the room, and it happens to also be accurate.

Then, if she wants more, I go one layer deeper.

What's Actually Happening to Dopamine?

Estradiol does two specific jobs in the dopamine system: it affects how sensitive your receptors are, and it affects how quickly dopamine clears out of the synapse after it's used. In animal studies, removing the ovaries dropped dopamine transporter density by 44% in a key reward-and-motivation region of the brain, and estradiol treatment reversed that.¹ Separately, cell studies show even low, physiological levels of estradiol change how fast dopamine is reused, within minutes.² That's laboratory evidence, not a scan of a human perimenopausal brain, but it's a clean, consistent picture: estradiol isn't making dopamine. It's tuning how much use your brain gets out of the dopamine it already has.

When I explain it this way, patients usually stop asking “what's wrong with me” and start asking “what do we do about the hormone.” That shift is the point of the explanation.

Why Do I Bring Up Norepinephrine, Acetylcholine, and Serotonin Too?

Because dopamine rarely travels alone in what a patient is describing. Estrogen also supports norepinephrine, which drives the ability to push through something boring, and acetylcholine, which underlies working memory: the ability to hold a thought long enough to use it. It supports serotonin too, which shows up less as focus and more as a shorter fuse, tears or frustration that arrive faster than they used to.

I bring this up because a patient who only hears “it's about dopamine” often thinks her case doesn't fit, because her main complaint is memory, or mood, or both. Naming all four systems at once tells her the whole cluster she's describing, not just the piece that matches the word “focus,” comes from the same hormonal source.

Does This Mean Hormone Therapy Is the Answer?

Sometimes, and I say that plainly rather than dodging it. For many patients, adequately dosed hormone therapy meaningfully improves focus, memory, and emotional regulation, because it restores part of the environment these neurotransmitter systems were built to run inside of. I don't prescribe hormone therapy myself; that decision, the dose, and the ongoing management belong with the prescribing practitioner overseeing a patient's care. What I do in the room is make sure that conversation happens with the right context in hand: not “I feel foggy,” but “here's the specific mechanism, here's my timeline, here's what I've already tried.”

Hormone therapy isn't a universal fix, and I don't present it as one. Some patients need it alongside a separate ADHD evaluation, not instead of one. Two different questions can be true in the same body at once.

What If a Patient Is Already on ADHD Medication?

This is where the conversation gets more specific, and where I'm most careful. If a stimulant that worked for years suddenly feels inadequate, the instinct is to ask for more of it. Often the real variable isn't the dose; it's that the hormonal environment the medication was working inside of changed. No randomized controlled trial has tested ADHD medication specifically in perimenopausal or menopausal women.³ That gap means current prescribing runs on consensus and extrapolation from younger patients, which is exactly why I tell patients this belongs in a direct conversation with their prescriber, one who knows that evidence gap exists, rather than a dose adjustment made alone.